Safety and Immune Response to a Clade C DNA HIV Vaccine
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Aurum Tembisa Crs
Johannesburg, Gauteng, South Africa
- Isipingo Crs
Westville, KwaZulu-Natal, South Africa
- Aurum Institute Klerksdorp Crs
Klerksdorp, North West, South Africa
- National Institute for Medical Research (nimr) - Mbeya Medical Research Center (mmrc) Network Crs
Mbeya, Tanzania
- Matero Reference Clinic Crs
Lusaka, Zambia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Jun 2016
- Primary completion
- 11 Jul 2018
- Completion
- 11 Jul 2018
- Last update posted
- 21 Jun 2019
- Registered enrollment
- 132
- Registry id
- NCT02997969
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.